Market News
Friday, December 23, 2016
UPDATE 1-FDA approves Biogen drug for lead genetic cause of infant death
Dec 23 (Reuters) - The U.S. Food and Drug Administration on
Friday said it has approved Biogen Inc's drug to treat
spinal muscular atrophy, the leading genetic cause of death in
infants.
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment